Sodium (2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-5-((((((((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1(4H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)oxidophosphoryl)oxy)oxidophosphoryl)oxy)methyl)-4-hydroxytetrahydrofuran-3-yl phosphate

Catalog No.: 
ACSNZO924
CAS No.: 
2646-71-1
Molecular Formula: 
C21H26N7Na4O17P3
Molecular Weight: 
833.35
Sodium (2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-5-((((((((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1(4H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)oxidophosphoryl)oxy)oxidophosphoryl)oxy)methyl)-4-hydroxytetrahydrofuran-3-yl phosphate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$95.00In stockInquiry
1g98%$283.00In stockInquiry
5g98%$854.00In stockInquiry
25g98%$3353.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSodium (2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-5-((((((((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1(4H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)oxidophosphoryl)oxy)oxidophosphoryl)oxy)methyl)-4-hydroxytetrahydrofuran-3-yl phosphate
IUPAC NameSodium (2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-5-((((((((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1(4H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)oxidophosphoryl)oxy)oxidophosphoryl)oxy)methyl)-4-hydroxytetrahydrofuran-3-yl phosphate
Molecular FormulaC21H26N7Na4O17P3
Molecular Weight833.35
SMILESO=P(O[C@H]1[C@@H](O[C@@H]([C@H]1O)COP(OP(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)N3C=CCC(C(N)=O)=C3)(O[Na])=O)(O[Na])=O)N4C5=C(N=C4)C(N)=NC=N5)(O[Na])O[Na]
InChI KeyWYWWVJHQDVCHKF-ITGWJZMWSA-J
Synonymβ-Nicotinamide Adenine Dinucleotide Phosphate Tetrasodium Salt reduced form [for Biochemical Research] | β-NADPH Tetrasodium Salt reduced form | TPNH Tetrasodium Salt reduced form | TPNH Tetrasodium Salt reduced form | β-Triphosphopyridine Nucleotide Tetr
CAS No.2646-71-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Comments (0)